$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 34 35 36 37 38 39 40 41 42 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 4.78 | 31,600 | 151,089 | 86,600 | 55 K to 86.6 K (+57.45 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 32.02 | 24,000 | 768,480 | 84,670 | |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.06 | 2,264 | 140,504 | 1,254 | 3.5 K to 1.3 K (-64.35 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.05 | 1,400 | 86,870 | 3,518 | 4.9 K to 3.5 K (-28.47 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.04 | 4,006 | 248,532 | 4,918 | 8.9 K to 4.9 K (-44.89 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.03 | 400 | 24,812 | 8,924 | 9.3 K to 8.9 K (-4.29 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.02 | 3,162 | 196,107 | 9,324 | 12.5 K to 9.3 K (-25.32 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.01 | 900 | 55,809 | 12,486 | 13.4 K to 12.5 K (-6.72 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.00 | 11,868 | 735,816 | 13,386 | 25.3 K to 13.4 K (-46.99 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 32.02 | 24,000 | 768,480 | 25,254 | 1.3 K to 25.3 K (+1,913.88 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | M | 7.30 | 53,896 | 393,274 | 0 | |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 62.73 | 168 | 10,539 | 37,679 | 37.8 K to 37.7 K (-0.44 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 62.72 | 1,334 | 83,668 | 37,847 | 39.2 K to 37.8 K (-3.40 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 62.71 | 400 | 25,084 | 39,181 | 39.6 K to 39.2 K (-1.01 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 62.70 | 21,994 | 1,379,024 | 39,581 | 61.6 K to 39.6 K (-35.72 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 62.32 | 1,640 | 102,205 | 61,575 | 63.2 K to 61.6 K (-2.59 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 62.30 | 28,360 | 1,766,828 | 63,215 | 91.6 K to 63.2 K (-30.97 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 7.30 | 53,896 | 393,274 | 91,575 | 37.7 K to 91.6 K (+143.04 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | M | 7.30 | 30,000 | 218,907 | 53,896 | |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 61.90 | 29,465 | 1,823,884 | 37,679 | 67.1 K to 37.7 K (-43.88 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 61.91 | 200 | 12,382 | 67,144 | 67.3 K to 67.1 K (-0.30 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 61.92 | 335 | 20,743 | 67,344 | 67.7 K to 67.3 K (-0.49 %) |
| Aug 10 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 7.30 | 30,000 | 218,907 | 67,679 | 37.7 K to 67.7 K (+79.62 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 16.44 | 120,000 | 1,972,500 | 133,920 | |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.43 | 5,000 | 302,128 | 518,581 | 523.6 K to 518.6 K (-0.95 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.47 | 20,000 | 1,209,450 | 523,581 | 543.6 K to 523.6 K (-3.68 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.48 | 7,500 | 453,600 | 543,581 | 551.1 K to 543.6 K (-1.36 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.48 | 12,500 | 756,038 | 551,081 | 563.6 K to 551.1 K (-2.22 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.50 | 7,500 | 453,725 | 563,581 | 571.1 K to 563.6 K (-1.31 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.50 | 12,500 | 756,268 | 571,081 | 583.6 K to 571.1 K (-2.14 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.51 | 10,000 | 605,100 | 583,581 | 593.6 K to 583.6 K (-1.68 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.53 | 25,000 | 1,513,158 | 593,581 | 618.6 K to 593.6 K (-4.04 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.59 | 7,500 | 454,423 | 618,581 | 626.1 K to 618.6 K (-1.20 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 60.59 | 12,500 | 757,434 | 626,081 | 638.6 K to 626.1 K (-1.96 %) |
| Aug 03 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 16.44 | 120,000 | 1,972,500 | 638,581 | 518.6 K to 638.6 K (+23.14 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 29,640 | 84,753 | 455,392 | |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 3.27 | 90,360 | 295,089 | 0 | |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.50 | 29,640 | 1,793,220 | 736,909 | 766.5 K to 736.9 K (-3.87 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 29,640 | 84,753 | 766,549 | 736.9 K to 766.5 K (+4.02 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.50 | 36,860 | 2,230,030 | 736,909 | 773.8 K to 736.9 K (-4.76 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.51 | 10,000 | 605,100 | 773,769 | 783.8 K to 773.8 K (-1.28 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.53 | 6,000 | 363,180 | 783,769 | 789.8 K to 783.8 K (-0.76 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.55 | 6,500 | 393,575 | 789,769 | 796.3 K to 789.8 K (-0.82 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.60 | 15,000 | 909,000 | 796,269 | 811.3 K to 796.3 K (-1.85 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.67 | 11,000 | 667,370 | 811,269 | 822.3 K to 811.3 K (-1.34 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.71 | 5,000 | 303,550 | 822,269 | 827.3 K to 822.3 K (-0.60 %) |
| Aug 02 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 3.27 | 90,360 | 295,089 | 827,269 | 736.9 K to 827.3 K (+12.26 %) |
| Jul 28 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | A | 61.89 | 30,000 | 1,856,700 | 30,000 | |
| Jul 28 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | A | 61.89 | 40,000 | 2,475,600 | 40,000 | |
| Jul 28 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | A | 61.89 | 40,000 | 2,475,600 | 40,000 | |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 17,824 | 209,573 | 0 | |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.40 | 42,176 | 312,039 | 33,816 | |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.94 | 500 | 30,470 | 98,521 | 99 K to 98.5 K (-0.50 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.87 | 4,345 | 264,480 | 99,021 | 103.4 K to 99 K (-4.20 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.85 | 3,149 | 191,617 | 103,366 | 106.5 K to 103.4 K (-2.96 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.84 | 900 | 54,756 | 106,515 | 107.4 K to 106.5 K (-0.84 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.83 | 1,000 | 60,830 | 107,415 | 108.4 K to 107.4 K (-0.92 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.82 | 300 | 18,246 | 108,415 | 108.7 K to 108.4 K (-0.28 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.81 | 5,684 | 345,644 | 108,715 | 114.4 K to 108.7 K (-4.97 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.80 | 1,546 | 93,997 | 114,399 | 115.9 K to 114.4 K (-1.33 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.79 | 400 | 24,316 | 115,945 | 116.3 K to 115.9 K (-0.34 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 17,824 | 209,573 | 116,345 | 98.5 K to 116.3 K (+18.09 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.80 | 42,176 | 2,564,301 | 98,521 | 140.7 K to 98.5 K (-29.98 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 7.40 | 42,176 | 312,039 | 140,697 | 98.5 K to 140.7 K (+42.81 %) |
| Jul 26 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 62.00 | 5,000 | 310,000 | 32,036 | 37 K to 32 K (-13.50 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.62 | 200 | 12,324 | 9,000 | 9.2 K to 9 K (-2.17 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 62.08 | 100 | 6,208 | 9,200 | 9.3 K to 9.2 K (-1.08 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 62.02 | 100 | 6,202 | 9,300 | 9.4 K to 9.3 K (-1.06 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 62.02 | 100 | 6,202 | 9,400 | 9.5 K to 9.4 K (-1.05 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 62.01 | 100 | 6,201 | 9,500 | 9.6 K to 9.5 K (-1.04 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.95 | 100 | 6,195 | 9,600 | 9.7 K to 9.6 K (-1.03 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.92 | 200 | 12,384 | 9,700 | 9.9 K to 9.7 K (-2.02 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.88 | 100 | 6,188 | 9,900 | 10 K to 9.9 K (-1.00 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.87 | 100 | 6,187 | 10,000 | 10.1 K to 10 K (-0.99 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.86 | 100 | 6,186 | 10,100 | 10.2 K to 10.1 K (-0.98 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.84 | 100 | 6,184 | 10,200 | 10.3 K to 10.2 K (-0.97 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.81 | 100 | 6,181 | 10,300 | 10.4 K to 10.3 K (-0.96 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.76 | 100 | 6,176 | 10,400 | 10.5 K to 10.4 K (-0.95 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.75 | 200 | 12,350 | 10,500 | 10.7 K to 10.5 K (-1.87 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.74 | 300 | 18,523 | 10,700 | 11 K to 10.7 K (-2.73 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 6,500 | 31,078 | 68,500 | |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.74 | 200 | 12,349 | 11,000 | 11.2 K to 11 K (-1.79 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.74 | 100 | 6,174 | 11,200 | 11.3 K to 11.2 K (-0.88 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.72 | 100 | 6,172 | 11,300 | 11.4 K to 11.3 K (-0.88 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.70 | 200 | 12,340 | 11,400 | 11.6 K to 11.4 K (-1.72 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.70 | 100 | 6,170 | 11,600 | 11.7 K to 11.6 K (-0.85 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.68 | 100 | 6,168 | 11,700 | 11.8 K to 11.7 K (-0.85 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.66 | 200 | 12,333 | 11,800 | 12 K to 11.8 K (-1.67 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.66 | 400 | 24,664 | 12,000 | 12.4 K to 12 K (-3.23 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.65 | 200 | 12,330 | 12,400 | 12.6 K to 12.4 K (-1.59 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.62 | 200 | 12,325 | 12,600 | 12.8 K to 12.6 K (-1.56 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.56 | 300 | 18,467 | 12,800 | 13.1 K to 12.8 K (-2.29 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.51 | 100 | 6,151 | 13,100 | 13.2 K to 13.1 K (-0.76 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.44 | 100 | 6,144 | 13,200 | 13.3 K to 13.2 K (-0.75 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.43 | 200 | 12,286 | 13,300 | 13.5 K to 13.3 K (-1.48 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.39 | 300 | 18,416 | 13,500 | 13.8 K to 13.5 K (-2.17 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.35 | 100 | 6,135 | 13,800 | 13.9 K to 13.8 K (-0.72 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.33 | 300 | 18,399 | 13,900 | 14.2 K to 13.9 K (-2.11 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.32 | 100 | 6,132 | 14,200 | 14.3 K to 14.2 K (-0.70 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.31 | 200 | 12,262 | 14,300 | 14.5 K to 14.3 K (-1.38 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.25 | 100 | 6,125 | 14,500 | 14.6 K to 14.5 K (-0.68 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.24 | 300 | 18,371 | 14,600 | 14.9 K to 14.6 K (-2.01 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.24 | 300 | 18,371 | 14,900 | 15.2 K to 14.9 K (-1.97 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.19 | 100 | 6,119 | 15,200 | 15.3 K to 15.2 K (-0.65 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.10 | 100 | 6,110 | 15,300 | 15.4 K to 15.3 K (-0.65 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.06 | 50 | 3,053 | 15,400 | 15.5 K to 15.4 K (-0.32 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 61.05 | 50 | 3,053 | 15,450 | 15.5 K to 15.5 K (-0.32 %) |
| Jul 14 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Buy | M | 4.78 | 6,500 | 31,078 | 15,500 | 9 K to 15.5 K (+72.22 %) |
| Jul 06 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 59.26 | 472 | 27,971 | 472 | |
| Jul 06 2006 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 59.26 | 1,012 | 59,971 | 1,012 | |
| Jul 06 2006 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 59.26 | 506 | 29,986 | 506 | |
| Jun 26 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.06 | 1,788 | 23,356 | 1,788 | |
| Jun 26 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 9.81 | 1,000 | 9,810 | 0 | |
| Jun 26 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.06 | 1,788 | 23,356 | 37,036 | 35.2 K to 37 K (+5.07 %) |
| Jun 26 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 9.81 | 1,000 | 9,810 | 35,248 | 34.2 K to 35.2 K (+2.92 %) |
| May 22 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 19,968 | 57,096 | 0 | |
| May 22 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 19,968 | 57,096 | 736,909 | 716.9 K to 736.9 K (+2.79 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 3.27 | 120,000 | 391,884 | 90,360 | |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 57.09 | 17,500 | 999,075 | 716,941 | 734.4 K to 716.9 K (-2.38 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 57.08 | 17,500 | 998,900 | 734,441 | 751.9 K to 734.4 K (-2.33 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 57.07 | 15,000 | 856,050 | 751,941 | 766.9 K to 751.9 K (-1.96 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 57.05 | 10,000 | 570,500 | 766,941 | 776.9 K to 766.9 K (-1.29 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 57.04 | 3,000 | 171,120 | 776,941 | 779.9 K to 776.9 K (-0.38 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 57.02 | 22,000 | 1,254,440 | 779,941 | 801.9 K to 779.9 K (-2.74 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 57.00 | 35,000 | 1,995,000 | 801,941 | 836.9 K to 801.9 K (-4.18 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 3.27 | 120,000 | 391,884 | 836,941 | 716.9 K to 836.9 K (+16.74 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 1,323 | 0 | 716,941 | 718.3 K to 716.9 K (-0.18 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 1,606 | 0 | 718,264 | 719.9 K to 718.3 K (-0.22 %) |
| May 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 8,347 | 0 | 719,870 | 728.2 K to 719.9 K (-1.15 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 16.44 | 100,000 | 1,643,750 | 253,920 | |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 55.55 | 25,000 | 1,388,750 | 518,581 | 543.6 K to 518.6 K (-4.60 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 55.60 | 20,000 | 1,112,092 | 543,581 | 563.6 K to 543.6 K (-3.55 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 55.62 | 7,500 | 417,120 | 563,581 | 571.1 K to 563.6 K (-1.31 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 55.63 | 7,500 | 417,225 | 571,081 | 578.6 K to 571.1 K (-1.30 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 55.65 | 7,500 | 417,338 | 578,581 | 586.1 K to 578.6 K (-1.28 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 55.65 | 5,000 | 278,250 | 586,081 | 591.1 K to 586.1 K (-0.85 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 55.67 | 15,000 | 835,050 | 591,081 | 606.1 K to 591.1 K (-2.47 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 55.75 | 12,500 | 696,875 | 606,081 | 618.6 K to 606.1 K (-2.02 %) |
| May 18 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 16.44 | 100,000 | 1,643,750 | 618,581 | 518.6 K to 618.6 K (+19.28 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 4.78 | 40,000 | 191,252 | 31,600 | |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | A | 57.35 | 33,750 | 1,935,563 | 33,750 | |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.69 | 4,000 | 230,760 | 55,000 | 59 K to 55 K (-6.78 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.68 | 4,000 | 230,720 | 59,000 | 63 K to 59 K (-6.35 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.67 | 2,000 | 115,340 | 63,000 | 65 K to 63 K (-3.08 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.66 | 4,054 | 233,754 | 65,000 | 69.1 K to 65 K (-5.87 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.65 | 5,800 | 334,370 | 69,054 | 74.9 K to 69.1 K (-7.75 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.64 | 2,313 | 133,321 | 74,854 | 77.2 K to 74.9 K (-3.00 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.63 | 200 | 11,526 | 77,167 | 77.4 K to 77.2 K (-0.26 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.62 | 3,133 | 180,523 | 77,367 | 80.5 K to 77.4 K (-3.89 %) |
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 57.60 | 4,500 | 259,200 | 80,500 | 85 K to 80.5 K (-5.29 %) |